Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00025844 · ClinicalTrials.gov registry record
Fear Conditioning Using Computer-Generated Virtual Reality
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 202
- Enrollment target
NCT00025844: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00025844 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 202 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00025844 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 202 participants
- Enrollment target
Study Summary
The purpose of this study is to use a computer-generated virtual reality environment to study fear conditioning. Fear conditioning is used to explore the causes and persistence of anxiety and anxiety disorders. When confronted with fearful or unpleasant events, people can develop fear of specific cues that were associated with these events as well as to the environmental context in which the events occurred via a process called classical or aversive conditioning. Advances in computer-generated visual stimulations could facilitate the design of new aversive conditioning studies. This study will develop a virtual reality environment to examine human contextual fear conditioning in the laboratory. During the procedure, moderately painful stimuli will be administered. Participants in this study will be screened with a medical history, physical examination, psychiatric evaluation, and hearing test. Participants will wear headphones and special goggles that will enable them to view a virtual reality environment. Measures will be taken during the study to see how the brain adapts to environmental stimuli.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2001-10-22 |
| Est. Completion | 2012-04-10 |
What the finished NCT00025844 record still lists
NCT00025844 is an observational study that tracks outcomes without assigning an intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00025844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00025844 about?
NCT00025844 is a clinical study titled "Fear Conditioning Using Computer-Generated Virtual Reality". The purpose of this study is to use a computer-generated virtual reality environment to study fear conditioning. Fear conditioning is used to explore the causes and persistence of anxiety and anxiety disorders. When confronted with fearful or unpleasant events, people can develop fear of specific c...
What is the current status of trial NCT00025844?
This trial is currently completed. The enrollment target is 202 participants. The study started on 2001-10-22. Estimated completion is 2012-04-10.
Who is sponsoring clinical trial NCT00025844?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI